Compared to DPP4 inhibitor, GLP-1RA use was associated with decreased risks of 30 outcomes, including respiratory failure, pneumonia, anemia, post-thrombotic sequelae, and bacterial infections, and increased risk of 13 outcomes, including sleep disturbances, nausea, vomiting, headaches, hypotension, sleep disturbances, and nephrolithiasis
It is not a sign of cardiac arrest and typically resolves once you calm down
If youre prepared for what comes after surgery, then it can work well
Read more Whether or not Aetna covers Wegovy, there's a path that skips insurance Aetna covers Wegovy as preferred on commercial plans but sets a BMI 35 or higher bar for weight-loss-only PA and excludes weight-loss use on Medicare Advantage
This means that many people who experienced DVTs as a result of taking Ozempic were at risk for PE